Clinical assessment of serum hepcidin isoforms associated with iron homeostasis and erythropoiesis-stimulating agent response in CKD patients
Not Applicable
- Conditions
- CKD
- Registration Number
- JPRN-UMIN000003427
- Lead Sponsor
- iizuka Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
These patients were excluded with severe inflammatory disease, infection, cancer, hematological disorders or blood transfusion within 4 weeks.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The relationship between the change of serum hepcidin and the responsiveness to erythropoiesis-stimulating agent
- Secondary Outcome Measures
Name Time Method To evaluate the association of serum hepcidin, iron-related biomarker, erythropoitic activity and serum cytokine